(Q43198953)

15 November 2017

title

Nicotine hapten structure, antibody selectivity and effect relationships: results from a nicotine vaccine screening procedure (English)

1 reference

15 November 2017

1 reference

0 references

Sabina H L de Villiers

1

1 reference

15 November 2017

Nina Lindblom

2

1 reference

15 November 2017

Genadiy Kalayanov

3

1 reference

15 November 2017

Sandra Gordon

4

1 reference

15 November 2017

Ivan Baraznenok

5

1 reference

15 November 2017

Anna Malmerfelt

6

1 reference

15 November 2017

Monica M Marcus

7

1 reference

15 November 2017

Anette M Johansson

8

1 reference

15 November 2017

Torgny H Svensson

9

1 reference

15 November 2017

language of work or name

English

0 references

publication date

7 January 2010

1 reference

15 November 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

15 November 2017

volume

28

1 reference

15 November 2017

issue

10

1 reference

15 November 2017

page(s)

2161-2168

1 reference

The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.051

Nicotinic effects on the firing pattern of midbrain dopamine neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.051

Selective stimulation of limbic dopamine activity by nicotine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.051

Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.051

Differential effects of acute and chronic nicotine on dopamine output in the core and shell of the rat nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.051

Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.051

Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.051

Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.051

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.051

Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.051

Varenicline in the treatment of tobacco dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.051

The immunogenicity and safety of a nicotine vaccine in smokers and nonsmokers: results of a randomized, placebo-controlled phase 1/2 trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.051

Safety and immunogenicity of a nicotine conjugate vaccine in current smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.051

A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.051

A vaccine against nicotine for smoking cessation: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.051

Radioimmunoassay of nicotine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.051

Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.051

Differential actions of typical and atypical antipsychotic drugs on dopamine release in the core and shell of the nucleus accumbens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.051

Nornicotine is self-administered intravenously by rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.051

Cotinine disposition and effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.051

Active immunization against nicotine suppresses nicotine-induced dopamine release in the rat nucleus accumbens shell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.051

Monoclonal nicotine-specific antibodies reduce nicotine distribution to brain in rats: dose- and affinity-response relationships

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.051

Active immunization against nicotine alters the distribution of nicotine but not the metabolism to cotinine in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.051

The effect of cotinine on nicotine- and cocaine-induced dopamine release in the nucleus accumbens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.051

Disconnection between activation and desensitization of autonomic nicotinic receptors by nicotine and cotinine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.051

Development of an anti-cotinine vaccine to potentiate nicotine-based smoking cessation strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.051

10.1016/J.VACCINE.2009.12.051

7 January 2021

Identifiers

DOI

1 reference

15 November 2017

1 reference